Vaccine prevention of maternal cytomegalovirus infection - Wikidata - awgldk - TriplyDB

Vaccine prevention of maternal cytomegalovirus infection

Vaccine prevention of maternal cytomegalovirus infection

http://www.wikidata.org/entity/Q24645631

about

Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant Cytomegalovirus Infection May Contribute to the Reduced Immune Function, Growth, Development, and Health of HIV-Exposed, Uninfected African Children Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?Cytomegalovirus in pregnancy: to screen or not to screen.Maternal immunization Immune regulation of human herpesviruses and its implications for human transplantation Understanding frailty, aging, and inflammation in HIV infection Vaccination in the elderly Congenital cytomegalovirus infection: Clinical presentation, epidemiology, diagnosis and prevention Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.Strain Variation and Disease Severity in Congenital Cytomegalovirus Infection: In Search of a Viral Marker Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein Cytomegalovirus infection in pregnancy An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France MF59™ as a vaccine adjuvant: a review of safety and immunogenicity.Imaging the fetal central nervous system.Educating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey.Cytomegalovirus: pathogen, paradigm, and puzzle Congenital cytomegalovirus infection in Canada: Active surveillance for cases diagnosed by paediatricians Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment Cytomegalovirus reinfections in healthy seroimmune women.Using the nonhuman primate model of HCMV to guide vaccine development Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responses.Detection of a single identical cytomegalovirus (CMV) strain in recently seroconverted young women.Comparison of multiple DNA vaccines for protection against cytomegalovirus infection in BALB/c mice.Preconception screening for cytomegalovirus: an effective preventive approach Enzyme-linked immunosorbent assay for measurement of cytomegalovirus glycoprotein B antibody in serum.Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States.Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies.Limited dissemination and shedding of the UL128 complex-intact, UL/b'-defective rhesus cytomegalovirus strain 180.92 Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus Prenatal neurologic anomalies: sonographic diagnosis and treatment.

P2860

Q21089588-0D149F79-1326-426A-8CA0-EAA41BFBBEBF Q24235578-56867CC1-9858-4C18-815E-C2732E15DFF1 Q24240129-876616BB-0A6E-4DBB-B957-2CE94EF40457 Q26742161-D66AD39A-F1C3-466C-9660-9A5B2A89CA76 Q26781359-829EDA42-89D1-4403-AD16-9364BF4600B4 Q26824199-845EEDAD-4FAB-421E-B0B2-B84439403893 Q26851794-6786F134-7838-42B7-86F3-58CE22884594 Q26853746-6469663D-B289-4321-A621-0F134920AECA Q26992146-129D07FF-E96D-46BD-A75F-047D4C806C06 Q27021143-C07C4808-6BBA-4BDE-82C0-4EF46FC34105 Q27022304-09EC80D0-BE24-43A7-8AB2-E89B3A8BE457 Q27024030-A7587588-708E-4A4F-B9A8-BA61572E2D99 Q27026924-1319CED9-D5FD-47B9-87F2-B526041F16BF Q27692570-FB5BFD37-E6DB-408B-A4AD-8B4FC0DADF2A Q28083202-BFB92449-0C47-47C9-975E-EB7DAB2BB8A6 Q28730561-56D434EB-2D7C-4D84-A461-E963231672F9 Q29994481-C1F7EDAE-9B37-412D-8AC6-2CA264F776C7 Q30352329-62668F80-2D60-46D6-8122-343F5444105D Q30359694-99FFA665-D791-4AE2-9934-02B414A486F1 Q30394545-778D8BC7-DBE6-4F04-B4D9-13C1721D56CF Q30439852-3ECA5580-A44B-4065-8F9E-CE25BFA2280E Q30606105-52807B8E-E461-45E4-B92E-DBB43D77D7EE Q33351523-0D547BEF-BCED-47C8-8A73-91BE6D76F396 Q33413926-C60FF1FE-2CBB-4391-9F63-ABC366DB480A Q33568646-A19F558D-DC61-493F-B037-2981F197ABA2 Q33583493-8E86409E-7F11-467E-AB68-D71CB189D1DB Q33584739-966B510A-6512-4AF1-84D6-11C10A88CEAA Q33585524-60EA660B-6A9F-4F50-BFEA-E5F053161777 Q33703139-BECA9A97-2A84-4351-B346-D138ACEB0583 Q33802905-01033624-7406-4C3A-938E-572E894850CD Q33813837-98D8A146-D0E5-4FDB-917D-ADD663785B44 Q33821096-2CDCFAA8-E0C0-4CAE-AB2F-7121A1C81FA5 Q33825662-10904817-6BCC-404F-9494-E32D3A40E69B Q33838430-1C128235-E1FA-4EE8-9084-BD521D4C59B3 Q33877783-7AD5DF70-C6FF-4FAD-943A-14B611183241 Q33903818-E814E968-2DD8-448B-878A-B74DF180FB11 Q33996614-CCD0F53A-FC17-4E66-A03D-03A8F167A98D Q34059228-C18344CC-36A2-4297-84A8-3D3E95F15CF4 Q34088164-6912549E-E029-4F8C-95D5-609849516AB4 Q34126947-0C931EA1-61E2-4B14-997B-7760C680AA37

P2860

Vaccine prevention of maternal cytomegalovirus infection

http://www.wikidata.org/entity/Q24645631

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Vaccine prevention of maternal cytomegalovirus infection

@ast

Vaccine prevention of maternal cytomegalovirus infection

@en

Vaccine prevention of maternal cytomegalovirus infection

@nl

type

label

Vaccine prevention of maternal cytomegalovirus infection

@ast

Vaccine prevention of maternal cytomegalovirus infection

@en

Vaccine prevention of maternal cytomegalovirus infection

@nl

prefLabel

Vaccine prevention of maternal cytomegalovirus infection

@ast

Vaccine prevention of maternal cytomegalovirus infection

@en

Vaccine prevention of maternal cytomegalovirus infection

@nl

P1433

Q24645631-79F3E9EE-5FAD-450E-A1F0-5A7B9A0604BD

P1476

Q24645631-9A5DB547-41CE-4B7F-8993-3476F409E2B5

P2093

Q24645631-1CCB42B9-4954-499B-B8A6-55912A3A50C5

Q24645631-2BA5F65D-50C1-4972-9C7A-25D154D4588E

Q24645631-37BEADB9-9DDC-4BC2-9B41-F0B0B5753B24

Q24645631-451E80BB-9F01-44AF-87A5-64A19B7D2440

Q24645631-6256CB31-9D30-42ED-9B92-537FC71C35D8

Q24645631-B1AAAD21-4687-411E-AF4E-279449DA40F3

Q24645631-D793C4E2-10E6-476E-AC28-81C0A49D0123

Q24645631-E722196E-174D-4F9C-A332-FCDE3100BA40

Q24645631-FFA2DB89-262F-4094-BBAA-BDDBD91218B5

P2860

Q24645631-1673C1ED-E456-4C4C-AD22-EBB8517E68DA

Q24645631-2832C88A-ACB9-4555-8AE9-73B36FD192D3

Q24645631-311B2B32-65F4-4B80-83E4-DE71834A6496

Q24645631-3BE7F587-D8AF-4E74-A030-3C27E43D6F42

Q24645631-3DB7E55F-5592-43B6-8987-019E0716EFE8

Q24645631-529BF742-F9AD-4C33-8B0D-E571BE868840

Q24645631-677E601E-0BF3-4FEE-8898-BC039F123642

Q24645631-7FB2F3CB-D872-4D13-B512-B217DFAFA67C

Q24645631-870ADD9C-2B67-4CFB-986E-20332428F248

Q24645631-8F39ACC2-1C38-451D-9A5A-5C4F5DD4BD93

P304

Q24645631-4DD893EF-DC83-4C58-AF0E-761DEF49DE2F

P31

Q24645631-897444D2-933F-46EB-9194-A81C0E668537

P3181

Q24645631-F8EBE0D9-F62E-483A-8B4C-B31670C07998

P356

Q24645631-FF47732E-CA99-422D-AB03-E9530B87E956

P407

Q24645631-996B90F5-9E2E-425C-B143-D952AFBFD052

P433

Q24645631-79628C39-1E9E-4A0E-906E-E502E4CBF270

P478

Q24645631-3DE83B63-F714-4484-90D3-0E35C247F21D

P50

Q24645631-5EF3AED7-144F-4CC0-83C6-C4C2A17BEF0E

Q24645631-D635AFFB-1E3B-4043-AE8C-45BD378285D2

P577

Q24645631-E203B369-7D0D-4AF3-AD8E-5AD41A6A91AC

P698

Q24645631-314B3DBA-888F-4E71-B1A6-7B765040E2E9

P921

Q24645631-A54B202B-7540-476A-9AB9-823D7E09E610

P932

Q24645631-FD642D6C-E14F-46A8-8582-876239AE2891

P3181

P356

P1433

The New England Journal of Medicine

P1476

Vaccine prevention of maternal cytomegalovirus infection

@en

P2093

Ashley Evans

http://www.w3.org/2001/XMLSchema#string

Changpin Zhang

http://www.w3.org/2001/XMLSchema#string

Cynthia Flanigan

http://www.w3.org/2001/XMLSchema#string

Elizabeth Davis

http://www.w3.org/2001/XMLSchema#string

Gretchen Cloud

http://www.w3.org/2001/XMLSchema#string

Janie Hill

http://www.w3.org/2001/XMLSchema#string

Robert F Pass

http://www.w3.org/2001/XMLSchema#string

Tina Simpson

http://www.w3.org/2001/XMLSchema#string

William Andrews

http://www.w3.org/2001/XMLSchema#string

P2860

A multiple testing procedure for clinical trials

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies

Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.

Congenital cytomegalovirus infection and disease in Sweden and the relative importance of primary and secondary maternal infections. Preliminary findings from a prospective study.

Maternal immunity and prevention of congenital cytomegalovirus infection.

Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine.

Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.

Detection of cytomegalovirus infection during clinical trials of glycoprotein B vaccine.

Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection.

Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers.

P304

1191-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

222131

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA0804749

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19297572

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

2753425

http://www.w3.org/2001/XMLSchema#string